en

PRODUCT DETAIL

JIDINUM 25 mg filmom obalené tablety

Code 0831E
MA number 18/0120/22-S
Product Form: tbl flm 30x25 mg (blis.PA/Al/PVC/Al)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
Therapeutic Class: 18 - ANTIDIABETICA (VRÁTANE INZULÍNU)
ATC:
A ALIMENTARY TRACT AND METABOLISM
A10 DRUGS USED IN DIABETES
A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
A10BH Dipeptidyl peptidase 4 (DPP-4) inhibitors
A10BH01 Sitagliptin
Shelf life: 24
Container: blister PA/Al/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 23.05.2022
Validity: 23.05.2027
SPC: SPC_JIDINUM_05 2022.pdf  
PIL: PIL_JIDINUM_05 2022.pdf  
Safety feature Yes
Data update: 25.05.2022
eu-flag.png sk-flag.png